A prospective evaluation of thiamine and magnesium status in relation to clinicopathological characteristics and 1-year mortality in patients with alcohol withdrawal syndrome
Alcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is rarely examined. The aim of the present study was to examine the relationship between thiamine and magnesium status in patients with AWS. Patients (n = 127) presen...
Saved in:
| Published in: | Journal of translational medicine Vol. 17; no. 1; p. 384 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
BioMed Central Ltd
21-11-2019
BioMed Central BMC |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Alcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is rarely examined. The aim of the present study was to examine the relationship between thiamine and magnesium status in patients with AWS.
Patients (n = 127) presenting to the Emergency Department with AWS were recruited to a prospective observational study. Blood samples were drawn to measure whole blood thiamine diphosphate (TDP) and serum magnesium concentrations. Routine biochemistry and haematology assays were also conducted. The Glasgow Modified Alcohol Withdrawal Score (GMAWS) measured severity of AWS. Seizure history and current medications were also recorded.
The majority of patients (99%) had whole blood TDP concentration within/above the reference interval (275-675 ng/gHb) and had been prescribed thiamine (70%). In contrast, the majority of patients (60%) had low serum magnesium concentrations (< 0.75 mmol/L) and had not been prescribed magnesium (93%). The majority of patients (66%) had plasma lactate concentrations above 2.0 mmol/L. At 1 year, 13 patients with AWS had died giving a mortality rate of 11%. Male gender (p < 0.05), BMI < 20 kg/m
(p < 0.01), GMAWS max ≥ 4 (p < 0.05), elevated plasma lactate (p < 0.01), low albumin (p < 0.05) and elevated serum CRP (p < 0.05) were associated with greater 1-year mortality. Also, low serum magnesium at time of recruitment to study and low serum magnesium at next admission were associated with higher 1-year mortality rates, (84% and 100% respectively; both p < 0.05).
The prevalence of low circulating thiamine concentrations were rare and it was regularly prescribed in patients with AWS. In contrast, low serum magnesium concentrations were common and not prescribed. Low serum magnesium was associated more severe AWS and increased 1-year mortality. |
|---|---|
| AbstractList | BACKGROUNDAlcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is rarely examined. The aim of the present study was to examine the relationship between thiamine and magnesium status in patients with AWS. METHODSPatients (n = 127) presenting to the Emergency Department with AWS were recruited to a prospective observational study. Blood samples were drawn to measure whole blood thiamine diphosphate (TDP) and serum magnesium concentrations. Routine biochemistry and haematology assays were also conducted. The Glasgow Modified Alcohol Withdrawal Score (GMAWS) measured severity of AWS. Seizure history and current medications were also recorded. RESULTSThe majority of patients (99%) had whole blood TDP concentration within/above the reference interval (275-675 ng/gHb) and had been prescribed thiamine (70%). In contrast, the majority of patients (60%) had low serum magnesium concentrations (< 0.75 mmol/L) and had not been prescribed magnesium (93%). The majority of patients (66%) had plasma lactate concentrations above 2.0 mmol/L. At 1 year, 13 patients with AWS had died giving a mortality rate of 11%. Male gender (p < 0.05), BMI < 20 kg/m2 (p < 0.01), GMAWS max ≥ 4 (p < 0.05), elevated plasma lactate (p < 0.01), low albumin (p < 0.05) and elevated serum CRP (p < 0.05) were associated with greater 1-year mortality. Also, low serum magnesium at time of recruitment to study and low serum magnesium at next admission were associated with higher 1-year mortality rates, (84% and 100% respectively; both p < 0.05). CONCLUSIONThe prevalence of low circulating thiamine concentrations were rare and it was regularly prescribed in patients with AWS. In contrast, low serum magnesium concentrations were common and not prescribed. Low serum magnesium was associated more severe AWS and increased 1-year mortality. Alcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is rarely examined. The aim of the present study was to examine the relationship between thiamine and magnesium status in patients with AWS. The majority of patients (99%) had whole blood TDP concentration within/above the reference interval (275-675 ng/gHb) and had been prescribed thiamine (70%). In contrast, the majority of patients (60%) had low serum magnesium concentrations (< 0.75 mmol/L) and had not been prescribed magnesium (93%). The majority of patients (66%) had plasma lactate concentrations above 2.0 mmol/L. At 1 year, 13 patients with AWS had died giving a mortality rate of 11%. Male gender (p < 0.05), BMI < 20 kg/m.sup.2 (p < 0.01), GMAWS max [greater than or equai to] 4 (p < 0.05), elevated plasma lactate (p < 0.01), low albumin (p < 0.05) and elevated serum CRP (p < 0.05) were associated with greater 1-year mortality. Also, low serum magnesium at time of recruitment to study and low serum magnesium at next admission were associated with higher 1-year mortality rates, (84% and 100% respectively; both p < 0.05). The prevalence of low circulating thiamine concentrations were rare and it was regularly prescribed in patients with AWS. In contrast, low serum magnesium concentrations were common and not prescribed. Low serum magnesium was associated more severe AWS and increased 1-year mortality. Background Alcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is rarely examined. The aim of the present study was to examine the relationship between thiamine and magnesium status in patients with AWS. Methods Patients (n = 127) presenting to the Emergency Department with AWS were recruited to a prospective observational study. Blood samples were drawn to measure whole blood thiamine diphosphate (TDP) and serum magnesium concentrations. Routine biochemistry and haematology assays were also conducted. The Glasgow Modified Alcohol Withdrawal Score (GMAWS) measured severity of AWS. Seizure history and current medications were also recorded. Results The majority of patients (99%) had whole blood TDP concentration within/above the reference interval (275–675 ng/gHb) and had been prescribed thiamine (70%). In contrast, the majority of patients (60%) had low serum magnesium concentrations (< 0.75 mmol/L) and had not been prescribed magnesium (93%). The majority of patients (66%) had plasma lactate concentrations above 2.0 mmol/L. At 1 year, 13 patients with AWS had died giving a mortality rate of 11%. Male gender (p < 0.05), BMI < 20 kg/m2 (p < 0.01), GMAWS max ≥ 4 (p < 0.05), elevated plasma lactate (p < 0.01), low albumin (p < 0.05) and elevated serum CRP (p < 0.05) were associated with greater 1-year mortality. Also, low serum magnesium at time of recruitment to study and low serum magnesium at next admission were associated with higher 1-year mortality rates, (84% and 100% respectively; both p < 0.05). Conclusion The prevalence of low circulating thiamine concentrations were rare and it was regularly prescribed in patients with AWS. In contrast, low serum magnesium concentrations were common and not prescribed. Low serum magnesium was associated more severe AWS and increased 1-year mortality. Background Alcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is rarely examined. The aim of the present study was to examine the relationship between thiamine and magnesium status in patients with AWS. Methods Patients (n = 127) presenting to the Emergency Department with AWS were recruited to a prospective observational study. Blood samples were drawn to measure whole blood thiamine diphosphate (TDP) and serum magnesium concentrations. Routine biochemistry and haematology assays were also conducted. The Glasgow Modified Alcohol Withdrawal Score (GMAWS) measured severity of AWS. Seizure history and current medications were also recorded. Results The majority of patients (99%) had whole blood TDP concentration within/above the reference interval (275-675 ng/gHb) and had been prescribed thiamine (70%). In contrast, the majority of patients (60%) had low serum magnesium concentrations (< 0.75 mmol/L) and had not been prescribed magnesium (93%). The majority of patients (66%) had plasma lactate concentrations above 2.0 mmol/L. At 1 year, 13 patients with AWS had died giving a mortality rate of 11%. Male gender (p < 0.05), BMI < 20 kg/m.sup.2 (p < 0.01), GMAWS max [greater than or equai to] 4 (p < 0.05), elevated plasma lactate (p < 0.01), low albumin (p < 0.05) and elevated serum CRP (p < 0.05) were associated with greater 1-year mortality. Also, low serum magnesium at time of recruitment to study and low serum magnesium at next admission were associated with higher 1-year mortality rates, (84% and 100% respectively; both p < 0.05). Conclusion The prevalence of low circulating thiamine concentrations were rare and it was regularly prescribed in patients with AWS. In contrast, low serum magnesium concentrations were common and not prescribed. Low serum magnesium was associated more severe AWS and increased 1-year mortality. Keywords: Alcohol withdrawal syndrome (AWS), Serum magnesium concentration, Circulating thiamine diphosphate (TDP), Pseudo-hypoxia, Plasma lactate concentrations, Glasgow modified alcohol withdrawal scale (GMAWS), Seizure kindling, 1-year mortality Abstract Background Alcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is rarely examined. The aim of the present study was to examine the relationship between thiamine and magnesium status in patients with AWS. Methods Patients (n = 127) presenting to the Emergency Department with AWS were recruited to a prospective observational study. Blood samples were drawn to measure whole blood thiamine diphosphate (TDP) and serum magnesium concentrations. Routine biochemistry and haematology assays were also conducted. The Glasgow Modified Alcohol Withdrawal Score (GMAWS) measured severity of AWS. Seizure history and current medications were also recorded. Results The majority of patients (99%) had whole blood TDP concentration within/above the reference interval (275–675 ng/gHb) and had been prescribed thiamine (70%). In contrast, the majority of patients (60%) had low serum magnesium concentrations (< 0.75 mmol/L) and had not been prescribed magnesium (93%). The majority of patients (66%) had plasma lactate concentrations above 2.0 mmol/L. At 1 year, 13 patients with AWS had died giving a mortality rate of 11%. Male gender (p < 0.05), BMI < 20 kg/m2 (p < 0.01), GMAWS max ≥ 4 (p < 0.05), elevated plasma lactate (p < 0.01), low albumin (p < 0.05) and elevated serum CRP (p < 0.05) were associated with greater 1-year mortality. Also, low serum magnesium at time of recruitment to study and low serum magnesium at next admission were associated with higher 1-year mortality rates, (84% and 100% respectively; both p < 0.05). Conclusion The prevalence of low circulating thiamine concentrations were rare and it was regularly prescribed in patients with AWS. In contrast, low serum magnesium concentrations were common and not prescribed. Low serum magnesium was associated more severe AWS and increased 1-year mortality. Alcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is rarely examined. The aim of the present study was to examine the relationship between thiamine and magnesium status in patients with AWS. Patients (n = 127) presenting to the Emergency Department with AWS were recruited to a prospective observational study. Blood samples were drawn to measure whole blood thiamine diphosphate (TDP) and serum magnesium concentrations. Routine biochemistry and haematology assays were also conducted. The Glasgow Modified Alcohol Withdrawal Score (GMAWS) measured severity of AWS. Seizure history and current medications were also recorded. The majority of patients (99%) had whole blood TDP concentration within/above the reference interval (275-675 ng/gHb) and had been prescribed thiamine (70%). In contrast, the majority of patients (60%) had low serum magnesium concentrations (< 0.75 mmol/L) and had not been prescribed magnesium (93%). The majority of patients (66%) had plasma lactate concentrations above 2.0 mmol/L. At 1 year, 13 patients with AWS had died giving a mortality rate of 11%. Male gender (p < 0.05), BMI < 20 kg/m (p < 0.01), GMAWS max ≥ 4 (p < 0.05), elevated plasma lactate (p < 0.01), low albumin (p < 0.05) and elevated serum CRP (p < 0.05) were associated with greater 1-year mortality. Also, low serum magnesium at time of recruitment to study and low serum magnesium at next admission were associated with higher 1-year mortality rates, (84% and 100% respectively; both p < 0.05). The prevalence of low circulating thiamine concentrations were rare and it was regularly prescribed in patients with AWS. In contrast, low serum magnesium concentrations were common and not prescribed. Low serum magnesium was associated more severe AWS and increased 1-year mortality. |
| ArticleNumber | 384 |
| Audience | Academic |
| Author | Adamson, Michael Kerr, Joanna-Lee Roussis, Xen McMillan, Donald C Forrest, Ewan Stefanowicz, Fiona Ross, David P Ireland, Alastair Colgan, Eoghan Bell, Hannah Galloway, Peter Robson, Gordon Talwar, Dinesh Burns, Alana Orr, Lesley Maguire, Donogh Catchpole, Anthony Young, David |
| Author_xml | – sequence: 1 givenname: Donogh orcidid: 0000-0002-0317-4079 surname: Maguire fullname: Maguire, Donogh email: Donogh.Maguire@glasgow.ac.uk, Donogh.Maguire@glasgow.ac.uk organization: Academic Unit of Surgery, School of Medicine, University of Glasgow, New Lister Building, Royal Infirmary, Glasgow, G31 2ER, Scotland, UK. Donogh.Maguire@glasgow.ac.uk – sequence: 2 givenname: Dinesh surname: Talwar fullname: Talwar, Dinesh organization: The Scottish Trace Element and Micronutrient Diagnostic and Reference Laboratory, Department of Biochemistry, Royal Infirmary, Glasgow, G31 2ER, Scotland, UK – sequence: 3 givenname: Alana surname: Burns fullname: Burns, Alana organization: Department of Biochemistry, Queen Elizabeth University Hospital, Glasgow, G51 4TF, Scotland, UK – sequence: 4 givenname: Anthony surname: Catchpole fullname: Catchpole, Anthony organization: The Scottish Trace Element and Micronutrient Diagnostic and Reference Laboratory, Department of Biochemistry, Royal Infirmary, Glasgow, G31 2ER, Scotland, UK – sequence: 5 givenname: Fiona surname: Stefanowicz fullname: Stefanowicz, Fiona organization: The Scottish Trace Element and Micronutrient Diagnostic and Reference Laboratory, Department of Biochemistry, Royal Infirmary, Glasgow, G31 2ER, Scotland, UK – sequence: 6 givenname: Gordon surname: Robson fullname: Robson, Gordon organization: Emergency Medicine Department, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, Scotland, UK – sequence: 7 givenname: David P surname: Ross fullname: Ross, David P organization: Academic Unit of Surgery, School of Medicine, University of Glasgow, New Lister Building, Royal Infirmary, Glasgow, G31 2ER, Scotland, UK – sequence: 8 givenname: David surname: Young fullname: Young, David organization: Department of Mathematics and Statistics, University of Strathclyde, 26 Richmond Street, Glasgow, G1 1XH, Scotland, UK – sequence: 9 givenname: Alastair surname: Ireland fullname: Ireland, Alastair organization: Emergency Medicine Department, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, Scotland, UK – sequence: 10 givenname: Ewan surname: Forrest fullname: Forrest, Ewan organization: Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, G4 0SF, Scotland, UK – sequence: 11 givenname: Peter surname: Galloway fullname: Galloway, Peter organization: Department of Biochemistry, Queen Elizabeth University Hospital, Glasgow, G51 4TF, Scotland, UK – sequence: 12 givenname: Michael surname: Adamson fullname: Adamson, Michael organization: Emergency Medicine Department, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, Scotland, UK – sequence: 13 givenname: Eoghan surname: Colgan fullname: Colgan, Eoghan organization: Emergency Medicine Department, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, Scotland, UK – sequence: 14 givenname: Hannah surname: Bell fullname: Bell, Hannah organization: Emergency Medicine Department, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, Scotland, UK – sequence: 15 givenname: Lesley surname: Orr fullname: Orr, Lesley organization: Emergency Medicine Department, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, Scotland, UK – sequence: 16 givenname: Joanna-Lee surname: Kerr fullname: Kerr, Joanna-Lee organization: Emergency Medicine Department, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, Scotland, UK – sequence: 17 givenname: Xen surname: Roussis fullname: Roussis, Xen organization: Emergency Medicine Department, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF, Scotland, UK – sequence: 18 givenname: Donald C surname: McMillan fullname: McMillan, Donald C organization: Academic Unit of Surgery, School of Medicine, University of Glasgow, New Lister Building, Royal Infirmary, Glasgow, G31 2ER, Scotland, UK |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31752901$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkstu3CAUhq0qVXNpX6CLCqmbbpwCtsFsKkVRL5EiddOu0QkczzCyYQo4o3mpPGOZmTTNVBULbv__wYH_vDrxwWNVvWX0krFefEyMKyFrylRNOWtZvXlRnbFWqrrrpTh5Nj6tzlNaUcrbrlWvqtOGyY4rys6qhyuyjiGt0WR3jwTvYZwhu-BJGEheOpicRwLekgkWHpObJ5Iy5DkR50nE8SDOgZjReWfCGvIyjGHhDIzELCGCyRhdys6kPYfVW4RIphAzjC5vd5xicuhzIhuXlwRGEwpjP7ERNgWUtt7GMOHr6uUAY8I3j_1F9fPL5x_X3-rb719vrq9ua9OJJtdDp7pmaDhnvBGyHagQnW0tciY4RSqBUUoVNj2gMkYoDmjvTGdE8VlhWHNR3Ry4NsBKr6ObIG51AKf3CyEuNMRS0ohaWEmxK1ClbDt0BkQHvR0sa3rDrRSF9enAWs93E1pTCo0wHkGPd7xb6kW416KXjZS8AD48AmL4NWPKenLJ4DiCxzAnzXffqaSkTZG-_0e6CnP05amKivdClWvSv6oFlAKcH0I51-yg-krQcqiQShbV5X9UpVmcykd7HFxZPzLwg8GURKWIw1ONjOpdYvUhsbokVu8TqzfF9O756zxZ_kS0-Q0V7Oyg |
| CitedBy_id | crossref_primary_10_15252_emmm_202216244 crossref_primary_10_1038_s41598_022_10970_x crossref_primary_10_3390_nu13061959 crossref_primary_10_3390_jcm11226755 crossref_primary_10_1016_j_nutres_2024_03_011 crossref_primary_10_37174_2587_7593_2023_6_2_57_65 crossref_primary_10_1080_00952990_2021_1889575 crossref_primary_10_1186_s12967_020_02645_w |
| Cites_doi | 10.1155/2017/6797460 10.1177/0036933013496944 10.1016/j.clnu.2005.06.004 10.1016/j.cell.2016.03.028 10.1093/clinchem/46.5.704 10.1093/alcalc/agt034 10.1016/S0140-6736(18)31310-2 10.1016/S0140-6736(99)00182-8 10.1024/0300-9831/a000159 10.1016/0009-8981(85)90137-8 10.1016/j.lfs.2007.05.005 10.1093/alcalc/37.6.513 10.1097/CCM.0000000000001659 10.3109/00365513.2013.773591 10.1016/j.clnesp.2018.02.007 10.1093/alcalc/ags111 10.1186/s13054-019-2435-4 10.1016/j.clnesp.2016.10.007 10.1038/nrgastro.2016.70 10.1093/ecam/nel089 10.1001/jama.2018.0158 10.1177/000456328802500617 10.1111/dar.12237 10.1111/nyas.13919 10.1093/oxfordjournals.alcalc.a008400 10.1093/qjmed/hcs020 10.1136/jnnp.37.8.959 10.1136/jech-2013-202574 10.1007/s40263-014-0163-5 10.1016/j.neuint.2013.01.009 10.1074/jbc.M300339200 10.1152/ajpendo.00526.2002 10.1093/alcalc/agh249 10.1002/prot.21880 10.1007/s12035-016-0079-9 10.1097/PSY.0b013e3182a151a7 10.1111/j.1749-6632.1969.tb13005.x 10.1007/s11065-012-9196-z 10.3177/jnsv.49.156 10.2165/00023210-200317140-00002 10.1016/j.annemergmed.2007.02.007 10.1038/srep45032 10.1111/eci.13152 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2019 |
| Copyright_xml | – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2019 |
| DBID | NPM AAYXX CITATION 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12967-019-02141-w |
| DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
| DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts Immunology Abstracts ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1479-5876 |
| EndPage | 384 |
| ExternalDocumentID | oai_doaj_org_article_6d70e5e0799d4f5ca65a8dfd138c2d76 A607376797 10_1186_s12967_019_02141_w 31752901 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | United Kingdom United Kingdom--UK United States--US Scotland |
| GeographicLocations_xml | – name: United Kingdom – name: United Kingdom--UK – name: United States--US – name: Scotland |
| GrantInformation_xml | – fundername: ; |
| GroupedDBID | --- -A0 0R~ 29L 2WC 3V. 53G 5VS 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACRMQ ADBBV ADINQ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ TR2 TUS UKHRP WOQ WOW XSB ~8M AAYXX CITATION 7T5 7XB 8FK AZQEC DWQXO EJD H94 K9. PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c563t-f5953f322123674f0665d4de21620e07a10009e38ae9cc692aedbc5c6595d6c13 |
| IEDL.DBID | RPM |
| ISSN | 1479-5876 |
| IngestDate | Tue Oct 22 15:13:52 EDT 2024 Tue Sep 17 21:10:34 EDT 2024 Fri Oct 25 10:47:37 EDT 2024 Fri Nov 22 20:01:46 EST 2024 Tue Nov 19 21:06:01 EST 2024 Tue Nov 12 23:12:03 EST 2024 Thu Nov 21 22:41:14 EST 2024 Sat Sep 28 08:28:09 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Circulating thiamine diphosphate (TDP) Glasgow modified alcohol withdrawal scale (GMAWS) 1-year mortality Pseudo-hypoxia Plasma lactate concentrations Seizure kindling Serum magnesium concentration Alcohol withdrawal syndrome (AWS) |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c563t-f5953f322123674f0665d4de21620e07a10009e38ae9cc692aedbc5c6595d6c13 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
| ORCID | 0000-0002-0317-4079 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873772/ |
| PMID | 31752901 |
| PQID | 2328690790 |
| PQPubID | 43076 |
| PageCount | 1 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_6d70e5e0799d4f5ca65a8dfd138c2d76 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6873772 proquest_miscellaneous_2317597703 proquest_journals_2328690790 gale_infotracmisc_A607376797 gale_infotracacademiconefile_A607376797 crossref_primary_10_1186_s12967_019_02141_w pubmed_primary_31752901 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-11-21 |
| PublicationDateYYYYMMDD | 2019-11-21 |
| PublicationDate_xml | – month: 11 year: 2019 text: 2019-11-21 day: 21 |
| PublicationDecade | 2010 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | Journal of translational medicine |
| PublicationTitleAlternate | J Transl Med |
| PublicationYear | 2019 |
| Publisher | BioMed Central Ltd BioMed Central BMC |
| Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
| References | 2141_CR12 J McLean (2141_CR27) 1999; 353 M Hillbom (2141_CR46) 2003; 17 AH Flannery (2141_CR13) 2016; 44 JB Jeppesen (2141_CR51) 2013; 73 D Talwar (2141_CR35) 2000; 46 T Quasim (2141_CR41) 2005; 24 RL Sweet (2141_CR20) 2013; 83 EM Ciszak (2141_CR28) 2003; 278 SK Das (2141_CR8) 2007; 81 KM Dingwall (2141_CR24) 2015; 34 D Maguire (2141_CR7) 2019 D Maguire (2141_CR50) 2018; 25 CC Cook (2141_CR38) 1998; 33 AD Thomson (2141_CR44) 2012; 22 I Pilchova (2141_CR19) 2017; 2017 AD Thomson (2141_CR23) 2002; 37 L Zieve (2141_CR26) 1969; 162 A McPherson (2141_CR6) 2012; 105 AD Thomson (2141_CR21) 2006; 41 M Onozuka (2141_CR15) 2003; 49 MW Donnino (2141_CR22) 2007; 50 D Lonsdale (2141_CR29) 2007; 4 W Gilmore (2141_CR1) 2016; 13 AD Thomson (2141_CR33) 2013; 48 2141_CR34 2141_CR32 2141_CR5 2141_CR2 RW Peake (2141_CR16) 2013; 58 D Shipton (2141_CR31) 2013; 67 AD Thomson (2141_CR43) 2013; 48 AS Hazell (2141_CR18) 2013; 62 M Baines (2141_CR39) 1988; 25 R Krishnadas (2141_CR30) 2013; 75 KC Whitfield (2141_CR37) 2018; 1430 EC Perry (2141_CR10) 2014; 28 GA Collaborators (2141_CR4) 2018; 392 S Zhu (2141_CR45) 2016; 165 SS Mortadza (2141_CR47) 2017; 7 D Maguire (2141_CR9) 2019; 49 RA Ghashut (2141_CR42) 2017; 17 AH Mokdad (2141_CR3) 2018; 319 PE Marik (2141_CR36) 2019; 23 IA Sevostyanova (2141_CR17) 2008; 71 MC Sugden (2141_CR49) 2003; 284 DC Traviesa (2141_CR25) 1974; 37 M Baines (2141_CR40) 1985; 153 K Osiezagha (2141_CR14) 2013; 10 L Amato (2141_CR11) 2011; 6 D Liu (2141_CR48) 2016; 54 |
| References_xml | – volume: 2017 start-page: 6797460 year: 2017 ident: 2141_CR19 publication-title: Oxid Med Cell Longev. doi: 10.1155/2017/6797460 contributor: fullname: I Pilchova – volume: 6 start-page: CD008537 year: 2011 ident: 2141_CR11 publication-title: Cochrane Database Syst Rev contributor: fullname: L Amato – ident: 2141_CR34 – volume: 58 start-page: 139 issue: 3 year: 2013 ident: 2141_CR16 publication-title: Scott Med J doi: 10.1177/0036933013496944 contributor: fullname: RW Peake – volume: 24 start-page: 956 issue: 6 year: 2005 ident: 2141_CR41 publication-title: Clin Nutr doi: 10.1016/j.clnu.2005.06.004 contributor: fullname: T Quasim – ident: 2141_CR5 – volume: 165 start-page: 704 issue: 3 year: 2016 ident: 2141_CR45 publication-title: Cell doi: 10.1016/j.cell.2016.03.028 contributor: fullname: S Zhu – volume: 46 start-page: 704 issue: 5 year: 2000 ident: 2141_CR35 publication-title: Clin Chem doi: 10.1093/clinchem/46.5.704 contributor: fullname: D Talwar – volume: 48 start-page: 514 issue: 4 year: 2013 ident: 2141_CR33 publication-title: Alcohol Alcohol doi: 10.1093/alcalc/agt034 contributor: fullname: AD Thomson – volume: 392 start-page: 1015 issue: 10152 year: 2018 ident: 2141_CR4 publication-title: Lancet doi: 10.1016/S0140-6736(18)31310-2 contributor: fullname: GA Collaborators – volume-title: An investigation into the role of thiamine and magnesium in the pathophysiology and treatment of alcohol withdrawal syndrome year: 2019 ident: 2141_CR7 contributor: fullname: D Maguire – volume: 353 start-page: 1768 issue: 9166 year: 1999 ident: 2141_CR27 publication-title: Lancet doi: 10.1016/S0140-6736(99)00182-8 contributor: fullname: J McLean – volume: 83 start-page: 188 issue: 3 year: 2013 ident: 2141_CR20 publication-title: Int J Vitam Nutr Res doi: 10.1024/0300-9831/a000159 contributor: fullname: RL Sweet – volume: 153 start-page: 43 issue: 1 year: 1985 ident: 2141_CR40 publication-title: Clin Chim Acta doi: 10.1016/0009-8981(85)90137-8 contributor: fullname: M Baines – volume: 81 start-page: 177 issue: 3 year: 2007 ident: 2141_CR8 publication-title: Life Sci doi: 10.1016/j.lfs.2007.05.005 contributor: fullname: SK Das – volume: 37 start-page: 513 issue: 6 year: 2002 ident: 2141_CR23 publication-title: Alcohol Alcohol doi: 10.1093/alcalc/37.6.513 contributor: fullname: AD Thomson – volume: 44 start-page: 1545 issue: 8 year: 2016 ident: 2141_CR13 publication-title: Crit Care Med doi: 10.1097/CCM.0000000000001659 contributor: fullname: AH Flannery – volume: 73 start-page: 293 issue: 4 year: 2013 ident: 2141_CR51 publication-title: Scand J Clin Lab Invest doi: 10.3109/00365513.2013.773591 contributor: fullname: JB Jeppesen – volume: 25 start-page: 8 year: 2018 ident: 2141_CR50 publication-title: Clin Nutr ESPEN. doi: 10.1016/j.clnesp.2018.02.007 contributor: fullname: D Maguire – volume: 48 start-page: 4 issue: 1 year: 2013 ident: 2141_CR43 publication-title: Alcohol Alcohol doi: 10.1093/alcalc/ags111 contributor: fullname: AD Thomson – volume: 23 start-page: 165 issue: 1 year: 2019 ident: 2141_CR36 publication-title: Crit Care doi: 10.1186/s13054-019-2435-4 contributor: fullname: PE Marik – ident: 2141_CR2 – volume: 17 start-page: 54 year: 2017 ident: 2141_CR42 publication-title: Clin Nutr ESPEN. doi: 10.1016/j.clnesp.2016.10.007 contributor: fullname: RA Ghashut – volume: 13 start-page: 426 issue: 7 year: 2016 ident: 2141_CR1 publication-title: Nat Rev Gastroenterol Hepatol. doi: 10.1038/nrgastro.2016.70 contributor: fullname: W Gilmore – volume: 4 start-page: 247 issue: 2 year: 2007 ident: 2141_CR29 publication-title: Evid Based Complement Alternat Med. doi: 10.1093/ecam/nel089 contributor: fullname: D Lonsdale – volume: 319 start-page: 1444 issue: 14 year: 2018 ident: 2141_CR3 publication-title: JAMA doi: 10.1001/jama.2018.0158 contributor: fullname: AH Mokdad – volume: 25 start-page: 698 issue: Pt 6 year: 1988 ident: 2141_CR39 publication-title: Ann Clin Biochem doi: 10.1177/000456328802500617 contributor: fullname: M Baines – volume: 34 start-page: 323 issue: 3 year: 2015 ident: 2141_CR24 publication-title: Drug Alcohol Rev. doi: 10.1111/dar.12237 contributor: fullname: KM Dingwall – volume: 1430 start-page: 3 issue: 1 year: 2018 ident: 2141_CR37 publication-title: Ann N Y Acad Sci doi: 10.1111/nyas.13919 contributor: fullname: KC Whitfield – volume: 33 start-page: 317 issue: 4 year: 1998 ident: 2141_CR38 publication-title: Alcohol Alcohol doi: 10.1093/oxfordjournals.alcalc.a008400 contributor: fullname: CC Cook – ident: 2141_CR32 – volume: 105 start-page: 649 issue: 7 year: 2012 ident: 2141_CR6 publication-title: QJM doi: 10.1093/qjmed/hcs020 contributor: fullname: A McPherson – volume: 37 start-page: 959 issue: 8 year: 1974 ident: 2141_CR25 publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.37.8.959 contributor: fullname: DC Traviesa – volume: 67 start-page: 805 issue: 10 year: 2013 ident: 2141_CR31 publication-title: J Epidemiol Commun Health doi: 10.1136/jech-2013-202574 contributor: fullname: D Shipton – volume: 28 start-page: 401 issue: 5 year: 2014 ident: 2141_CR10 publication-title: CNS Drugs doi: 10.1007/s40263-014-0163-5 contributor: fullname: EC Perry – volume: 62 start-page: 796 issue: 5 year: 2013 ident: 2141_CR18 publication-title: Neurochem Int doi: 10.1016/j.neuint.2013.01.009 contributor: fullname: AS Hazell – volume: 278 start-page: 21240 issue: 23 year: 2003 ident: 2141_CR28 publication-title: J Biol Chem doi: 10.1074/jbc.M300339200 contributor: fullname: EM Ciszak – volume: 284 start-page: E855 issue: 5 year: 2003 ident: 2141_CR49 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00526.2002 contributor: fullname: MC Sugden – volume: 41 start-page: 151 issue: 2 year: 2006 ident: 2141_CR21 publication-title: Alcohol Alcohol doi: 10.1093/alcalc/agh249 contributor: fullname: AD Thomson – volume: 71 start-page: 541 issue: 2 year: 2008 ident: 2141_CR17 publication-title: Proteins. doi: 10.1002/prot.21880 contributor: fullname: IA Sevostyanova – volume: 54 start-page: 5440 issue: 7 year: 2016 ident: 2141_CR48 publication-title: Mol Neurobiol doi: 10.1007/s12035-016-0079-9 contributor: fullname: D Liu – volume: 10 start-page: 26 issue: 4 year: 2013 ident: 2141_CR14 publication-title: Innov Clin Neurosci. contributor: fullname: K Osiezagha – volume: 75 start-page: 616 issue: 7 year: 2013 ident: 2141_CR30 publication-title: Psychosom Med doi: 10.1097/PSY.0b013e3182a151a7 contributor: fullname: R Krishnadas – ident: 2141_CR12 – volume: 162 start-page: 732 issue: 2 year: 1969 ident: 2141_CR26 publication-title: Ann N Y Acad Sci doi: 10.1111/j.1749-6632.1969.tb13005.x contributor: fullname: L Zieve – volume: 22 start-page: 81 issue: 2 year: 2012 ident: 2141_CR44 publication-title: Neuropsychol Rev doi: 10.1007/s11065-012-9196-z contributor: fullname: AD Thomson – volume: 49 start-page: 156 issue: 3 year: 2003 ident: 2141_CR15 publication-title: J Nutr Sci Vitaminol (Tokyo). doi: 10.3177/jnsv.49.156 contributor: fullname: M Onozuka – volume: 17 start-page: 1013 issue: 14 year: 2003 ident: 2141_CR46 publication-title: CNS Drugs doi: 10.2165/00023210-200317140-00002 contributor: fullname: M Hillbom – volume: 50 start-page: 715 issue: 6 year: 2007 ident: 2141_CR22 publication-title: Ann Emerg Med doi: 10.1016/j.annemergmed.2007.02.007 contributor: fullname: MW Donnino – volume: 7 start-page: 45032 year: 2017 ident: 2141_CR47 publication-title: Sci Rep. doi: 10.1038/srep45032 contributor: fullname: SS Mortadza – volume: 49 start-page: e13152 year: 2019 ident: 2141_CR9 publication-title: Eur J Clin Invest doi: 10.1111/eci.13152 contributor: fullname: D Maguire |
| SSID | ssj0024549 |
| Score | 2.3580885 |
| Snippet | Alcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is rarely examined. The... Background Alcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is rarely... BACKGROUNDAlcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is rarely... Abstract Background Alcohol withdrawal syndrome (AWS) is routinely treated with B-vitamins. However, the relationship between thiamine status and outcome is... |
| SourceID | doaj pubmedcentral proquest gale crossref pubmed |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 384 |
| SubjectTerms | Albumin Alcohol withdrawal Alcohol withdrawal syndrome (AWS) Alcoholism Analysis Biochemistry Blood levels Circulating thiamine diphosphate (TDP) Dehydrogenases Emergency medical services Enzymes Glasgow modified alcohol withdrawal scale (GMAWS) Glucose Hypoxia Lactates Lactic acid Magnesium Metabolism Mortality Patient outcomes Patients Plasma lactate concentrations Pseudo-hypoxia Pyrimidines Seizures (Medicine) Serum magnesium concentration Substance withdrawal syndrome Thiamine Thiamine diphosphate United Kingdom Vitamin B Vitamin deficiency Vitamins |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07j9QwEB7BFYgG8SZwICMhUSDr4jzsuFzgTtdAA0h0ltd2uC02OW02WvGn-I3M2MlyEQUNZWLHsjMPjz0z3wC8QZXnyP3G18gcvJJWcStDyb1qpBVK2TrQhdvlF_X5e_PxnGByjqW-KCYswQOnH3cmvcpDHXKlta_a2llZ28a3XpSNK7xKYNu5nA9TM8oeHnvmFJlGng24q0kKsdScMMIEPyy2oYjW_7dOvrEpLQMmb-xAF_fh3mQ6slWa8gO4FbqHcOfT5Bx_BL9WDMecUyfZHxxv1rdsf0UZ3F1gtvNsa3-ghtuMW0b5ROPANh3bTVFxbN-zlC7ZU7XiWTcyt0R2juMI_hMFhW2jCY_mPI0zAbUOjG54mU0VeOOD39kDDjRjJDyGbxfnXz9c8qkcA3e1LPe8rXVdtqgAIupb1ZLTxlc-FEIWORLIkqtAh7KxQTsndWGDX7vaEWKhl06UT-Ck67vwDFglW5m7Nld4eKrWFQH0oJ2EllJAvY1MlcG7mTrmOqFumHhaaaRJtDRISxNpaQ4ZvCcCHnsSYnZ8gXxkJj4y_-KjDN4S-Q3JNdLY2Sk9ASdMCFlmJVEZKqm0yuB00RPl0S2bZwYykz4YDNqtVPpL6TyD18dm-pJi3LrQj9QHTTk0x_Myg6eJ345LoibyeGegFpy4WPOypdtcRbRw2eDEVPH8f_ykF3C3ICESghfiFE72uzG8hNuDH19F-fsNquM4Gw priority: 102 providerName: Directory of Open Access Journals |
| Title | A prospective evaluation of thiamine and magnesium status in relation to clinicopathological characteristics and 1-year mortality in patients with alcohol withdrawal syndrome |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31752901 https://www.proquest.com/docview/2328690790 https://search.proquest.com/docview/2317597703 https://pubmed.ncbi.nlm.nih.gov/PMC6873772 https://doaj.org/article/6d70e5e0799d4f5ca65a8dfd138c2d76 |
| Volume | 17 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6xPVS9IN6ElspISByQu3nayXEprXopQgIkbpbXdtqVSFJtdrXiT_U3MuPESyNuHBM_ZGue9sx8BniPKs9Q-I0vkTl4LrTkWriMW1kKnUipC0cXblff5Jef5ecLgskpQi2MT9o3y9VZ-6s5a1e3PrfyrjHzkCc2_3p9LkqZoVc4n8EMfcNwRA8Ae3jiCdUxpZj3aNAEZVdWnODBEr47gkMymhRAnBgjj9n_r2Z-YJqmaZMP7NDlE3g8OpBsMSz0KTxy7TM4vB5D5M_hfsFwzlBAyf6iebOuZptbquNuHdOtZY2-QT232jaMqoq2PVu1bD3mxrFNx4aiyY7eLA4akpkpvrOfJ-G_UVxY4x15dOppnhGutWd0z8v08A6v_7BrvcOJAlLCC_hxefH9_IqPjzJwU4hsw-uiKrIa1YDHfstrCt3Y3Lo0EWnsYqkpYFC5rNSuMkZUqXZ2aQpDuIVWmCR7CQdt17rXwHJRi9jUscQjVL7MCaYHvSX0lxxqb2StCD4G6qi7AXtD-TNLKdRAVoVkVZ6sahfBJyLgvifhZvsf3fpGjdyjhJWxK3CZVWXzujBaFLq0tU2y0qRWigg-EPkVSTfS2OixSAEXTDhZaiFQJUohKxnByaQnSqWZNgcGUqNW6BV6r_QAmKziCN7tm2kkZbq1rttSH-RNdMrjLIJXA7_ttxTYNgI54cTJnqctKEIeM3wUmTf_PfIYjlISoiThaXICB5v11r2FWW-3p_4e49RL4R_qIDj8 |
| link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RIpVeeD8CBYyExAG5m6edHJfSahHdCokicbO8ttOuxCbVPrTiT_EbmXHi0ohbj4kdy5a_Gc9kZj4DvEeVZyj8xmcIDp4LLbkWLuNWlkInUurC0Q-3yXd59rP8fEw0OUWohfFJ-2Y2P2x-LQ6b-aXPrbxamFHIExt9mx6JUmZoFY524C7KaxwHJz1Q7KHPE-pjSjFa4ZEmKL-y4kQQlvDtPuzRsUkhxMFx5Fn7_9fNNw6nYeLkjZPo5MEt1_AQ7vemJxt3zY_gjmsew960D64_gT9jhnMJpZfsHw84a2u2vqQK8MYx3Vi20BeoIeebBaN6pM2KzRu27LPq2LplXbllS7cdB93KzJAZ2o-T8N8oaGzhXQB0B2icnuh1xegPMdPdDb7-wS71FgcKHAtP4cfJ8fnRhPfXOXBTiGzN66IqshoViGeNy2sK-tjcujQRaexiqSnUULms1K4yRlSpdnZmCkOMh1aYJHsGu03buBfAclGL2NSxROcrn-VE8IN2FlpaDvU-gjKCj2FX1VXH2qG8t1MK1cFBIRyUh4PaRvCJNv66JzFu-xft8kL1e6aElbErcJpVZfO6MFoUurS1TbLSpFaKCD4QbBTpBcSG0X15A06YGLbUWKAylUJWMoKDQU-UZzNsDsBTvT5ZKbR76eowWcURvLtupi8pR65x7Yb6IKbRnI-zCJ53OL1eUoB7BHKA4MGahy0IXM823gP15a2_fAv3JufTU3X65ezrK9hPSRCThKfJAeyulxv3GnZWdvPGy_BfTYRNlw |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RIq164U0JFDASEgfk5m0nx6XtqghaVQIkbpbXdtqV2GS1D634U_xGZpxkacQNjokdy5a_ecUznwHeosozdPzGpwgOngktuRYu5VYWQsdS6tzRD7fzL_Lye3F6RjQ5u6u-fNK-mc6O6x_z43p243MrF3MT9nli4dXFiShkil5huLBVuAd3UWajpA_Ue5o9jHv6GplChCs0a4JyLEtOJGEx3x7AiEwnHSMOTJJn7v9bP98yUMPkyVvWaHL_P9bxAO51Ligbt10ewh1XP4LRRXfI_hh-jRnOpy_BZH_4wFlTsfUNVYLXjunasrm-Rk0528wZ1SVtVmxWs2WXXcfWDWvLLhu69bjXscwMGaL9ODH_iQLH5j4UwLCAxukIX1eM_hQz3d7k6x_sUm9xoJ5r4Ql8m5x9PTnn3bUO3OQiXfMqL_O0QkXi2eOyig5_bGZdEoskcpHUdORQurTQrjRGlIl2dmpyQ8yHVpg4fQr7dVO7Z8AyUYnIVJHEICybZkT0g_4WelwO9T-CM4D3_c6qRcveoXzUUwjVQkIhJJSHhNoG8IE2f9eTmLf9i2Z5rbp9U8LKyOU4zbK0WZUbLXJd2MrGaWESK0UA7wg6ivQD4sPorswBJ0xMW2osUKlKIUsZwNGgJ8q1GTb34FOdXlkp9H_pCjFZRgG82TXTl5QrV7tmQ30Q1-jWR2kAhy1Wd0vqIR-AHKB4sOZhC4LXs453YH3-z1--htHV6UR9_nj56QUcJCSLccyT-Aj218uNewl7K7t55cX4N5PsUBc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+prospective+evaluation+of+thiamine+and+magnesium+status+in+relation+to+clinicopathological+characteristics+and+1-year+mortality+in+patients+with+alcohol+withdrawal+syndrome&rft.jtitle=Journal+of+translational+medicine&rft.au=Maguire%2C+Donogh&rft.au=Talwar%2C+Dinesh&rft.au=Burns%2C+Alana&rft.au=Catchpole%2C+Anthony&rft.date=2019-11-21&rft.eissn=1479-5876&rft.volume=17&rft.issue=1&rft.spage=384&rft.epage=384&rft_id=info:doi/10.1186%2Fs12967-019-02141-w&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1479-5876&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1479-5876&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1479-5876&client=summon |